1. Windfuhr JP. Laryngeal hamartoma. Acta Otolaryngol. 2004;124:301–8.
2. Kizilkilic O, Yalcin O, Yildirim T, Sener L, Parmaksiz G, Erdogan B. Hypotahlamic hamartoma associated with a craniopharyngeal canal. Am J Neuroradiol. 2005;26:65–7.
3. Mizuguchi M, Takashima S. Neuropathology of tuberous sclerosis. Brain Dev. 2001;23:508–15.
4. Lamb RF, Roy C, Diefenbach TJ, Vinters HV, Johnson MW, Jay DG, et al. The TSC1 tumor suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat Cell Biol. 2000;2:281–7.
5. Wienecke R, Konig A, DeClue JE. Identification of tuberin, the tuberous sclerosis-2 product. Tubern possesses specific Rap1GAP activity. J Biol Chem. 1995;270:16409–14.